Dave Youngberg joins the SPR Therapeutics team with over 25 years of experience in the medical device and pharmaceutical industry, most recently having served in sales leadership at Nevro. Prior to Nevro, Dave served as Vice President of Sales for CNS Therapeutics where he led the sales team in the launch of Gablofen. Mr. Youngberg continued with his position as head of the Intrathecal Sales Team after CNS was acquire by Covidien/Mallinckrodt in the fall of 2012. Prior to CNS, He was the Director of Sales for Restore Medical, which went public in 2006 and was later acquired by Medtronic. Mr. Youngberg has also held various sale leadership positions at Medtronic, Horizon Medical and Ethicon. He has a B.A. in Economics from the University of MN and served in the U.S. Navy.